Neurodegenerative Disease Treatment Strategy Sparked by Novel DLK Inhibitor

Neurodegenerative Disease Treatment Strategy Sparked by Novel DLK Inhibitor

Neurodegenerative conditions such as Parkinson’s disease and Alzheimer’s disease involve progressive neuronal loss due to disease-induced damage. An enzyme known as dual leucine-zipper kinase (DLK) plays a key role in this process, telling neurons that are damaged or unhealthy when they should cut their losses and self-destruct. While sparing neurons from DLK represents a potential therapeutic strategy for slowing disease progression, a clinical…